Ajit Shetty - 31 Mar 2025 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Reporting relationship: Director
Issuer ticker: ATNM
Reported as of: 31 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Apr 2025, 18:21:33 UTC
Prior SEC filing: 29 Dec 2023
Next SEC filing: 04 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Ajit Shetty

Key filing fact

Ajit Shetty filed Form 4 for Actinium Pharmaceuticals, Inc. (ATNM) on 02 Apr 2025.

Key facts

This page summarizes Ajit Shetty's Form 4 filing for Actinium Pharmaceuticals, Inc. (ATNM).
7 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 02 Apr 2025, 18:21.

Change

Previous filing in this sequence was filed on 29 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATNM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -2,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,500
Exercise price: $47.40
Footnotes: F1

ATNM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -2,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,500
Exercise price: $23.49
Footnotes: F1

ATNM transaction Derivative

tock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -8,333
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,333
Exercise price: $6.96
Footnotes: F1

ATNM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -8,333
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,333
Exercise price: $9.55
Footnotes: F1

ATNM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -18,351
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,351
Exercise price: $6.07
Footnotes: F1

ATNM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -72,156
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 72,156
Exercise price: $4.96
Footnotes: F1

ATNM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -70,311
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 70,311
Exercise price: $5.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration.